Eam Investors, LLC Dynavax Technologies Corp Transaction History

Eam Investors, LLC

  • $581 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$13.17 - $20.94 $2.84 Million - $4.51 Million
-215,420 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$9.16 - $19.83 $1.97 Million - $4.27 Million
215,420 New
215,420 $4.14 Million
Q4 2017

Feb 12, 2018
SELL
$17.3 - $24.08 $4.12 Million - $5.73 Million
-237,938 Closed
0 $0
Q3 2017

Nov 08, 2017
BUY
$15.2 - $21.5 $3.62 Million - $5.12 Million
237,938
237,938 $5.12 Million

Others Institutions Holding DVAX

# of Institutions
273
Shares Held
130M
Call Options Held
451K
Put Options Held
203K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.6B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Eam Investors, LLC Portfolio

Follow Eam Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Investors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email